Author/Authors :
Malekian، Arash نويسنده Department of Pediatrics, Division of Neonatology, Ahvaz
Jundishapur University of Medical Sciences, Ahvaz, IR
Iran , , Khalilian، Mohammad reza نويسنده Shahid Beheshti University of Medical Science, Tehran, Iran. , , Dehdashtian، Masoud نويسنده Pediatrician, Associate Professor, Department of Pediatrics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. , , Aramesh، Mohammad Reza نويسنده Assistant professor of Pediatrics, Department of Neonatology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. , , Heydaripoor، Khadijeh نويسنده Department of Pediatrics, Ahvaz Jundishapur University of
Medical Sciences, Ahvaz, IR Iran ,
Abstract :
Supraventricular Tachycardia (SVT) is the most frequent arrhythmia
requiring a medical treatment in neonates. The aim of our study was to
evaluate and manage neonatal supraventricular tachycardia. This study
was performed on 22 newborns that were diagnosed with SVT at two
neonatal intensive care units (NICU) in south west of Iran from October
2012 to October 2015. Data on gender, age, weight, maternal age,
gestational age, presence of congenital heart disease, blood pressure in
admission, duration of hospitalization period, duration of SVT, medicine
for the control of SVT, list of medicine administered at releasing time
were collected. Echocardiography was performed for all patients. Data
was analyzed by the SPSS version 18 software. Twelve neonates were male
(54.5%) and ten (45.5%) were female. The mean age was 11.68 ± 8.17 days.
Three neonates (13.6%) had congenital heart disease. The mean duration
of hospitalization was 6.54 ± 3.98 days. Nine patients (41%) only had
responded adenosine. One patient had hypotensive that received D/C
shock. We concluded that in most SVT patients, conventional treatment
can be helpful and an only minor percentage of patients need to receive
flecainide as the last line of treatment.
